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SUMMARY. The aim of the present research was to build a tool to classify patients according to drug ther-
aphy risk so as to rationalize the use of clinical pharmaceutical resources in hospital settings. Risk factors
selected in the literature available were carefully revised to be included in the score. The selected factors
were submitted to univariate and then to multivariate analysis. The significant results were included in the
final score model, which divided the hospitalized patients into three groups: low risk, moderate risk and
high risk. After that, the score was applied in the hospital and a “risk classification” map was created of
the various sectors of the Hospital de Clínicas de Porto Alegre. The score was applied to 1442 patients in
nine different areas of the hospital, with 398 (27.6 %) of them presenting high risk, 612 (42.4 %) moderate
risk and 432 (29.9 %) low risk. The high risk units were: Pediatric Oncology, the Intensive Care Unit
(ICU) for adults and the Pediatric Intensive Care Unit (PICU). The clinical and surgical units, the Protect-
ed Environment Unit (PEU) and the Neonatal Intensive Care Unit (NICU) were classified as moderate risk
and the pediatric hospitalization unit as low risk. Considering the patients with renal and/or hepatic prob-
lems, cardiac and/or pulmonary problems and immunosuppression and/or immuno deficiency, 50.2 %,
61.5 % and 52.6 %, respectively, presented high score, with all of them taking at least one risk drug. Re-
garding the number of drugs prescribed, the use of 0-5 drugs was verified in 68.8 % of the patients with
low score and the use of 11-15 drugs in 63.1 % of the patients with high score. The score developed in this
study showed a significant correlation between the risk groups and the profile of the patients hospitalized
in the analyzed areas. This tool will be validated to optimize pharmaceutical care resources.
